期刊文献+

血清炎性介质与冠状动脉粥样硬化性心脏病稳定性的关系 被引量:1

Association between the serum inflammatory markers and stability of coronary heart disease
下载PDF
导出
摘要 【目的】从临床、造影和血清炎性介质方面综合评估冠状动脉粥样硬化斑块的稳定性。【方法】结合临床表现、心肌酶变化、冠脉造影结果,207例住院患者分为急性心肌梗死组(acute myocardial infarction,AMI)30例、不稳定心绞痛组(unstable angina,UA)90例、稳定性心绞痛组(stable angina,SA)36例和正常对照组(normal control,N)51例。采用酶联免疫吸附法测定血清高敏C反应蛋白(high sensitive C reactive protein,HsCRP)和妊娠相关蛋白A(pregnancy-associated plasma protein-A,PAPPA)。【结果】AMI组肌红蛋白(myoglobin,MYO)较对照组明显升高,肌钙蛋白(troponin I,TNI)和肌酸激酶同工酶(MB isoenzyme of creatine kinase,CKMB)无明显升高。AMI组HsCRP和PAPPA较对照组明显升高,具有统计学意义(P<0.05)。线性相关分析显示MYO和HsCRP、PAPPA无明显相关,HsCRP和PAPPA呈正相关(r=0.57,P=0.032)。【结论】急性心肌梗死组炎性介质水平升高,早期检验对预测斑块稳定性有一定意义。 [Objective]To evaluate the stability of coronary disease with clinical manifestation,coronary angiography(CAG)and the levels of serum inflammatory markers.[Methods] A total of 207 patients with chest pain were divided into 4 groups based on the clinical manifestation,ECG changes,myocardial markers and coronary angiography(CAG):acute myocardial infarction AMI(n=30),unstable angina UA(n=90),stable angina SA(n=36),normal CAG(n=51).The serum levels of high sensitive C reactive protein and Pregnancy-associated plasma protein-A were measured in all the patients,and myocardial markers measured too.[Results] There were no difference either in Troponin Ⅰ(TNI)or MB isoenzyme of creatine kinase(CKMB)level,but the myoglobin(MYO)level was significantly increased in AMI than other groups.The serum level of Hs-CRP in AMI was higher only than normal group(7.41±9.91)mg/l vs(4.04±5.26)mg/l(P0.05),and the serum level of PAPPA in AMI was higher than UA group,SA group and normal group respectively(P0.05).[Conclusions] Serum level of Hs-CRP and PAPPA can be used as a good index reflecting the stability of coronary artery disease.
出处 《武警医学院学报》 CAS 2010年第3期172-174,共3页 Acta Academiae Medicinae CPAPF
关键词 血清炎性介质 斑块稳定性 高敏C反应蛋白 妊娠相关蛋白A Serum inflammation marker Plaque stability Hs-CRP Pregnancy-associated plasma protein-A
  • 相关文献

参考文献8

  • 1Hajek P,Macek M,Hladikova M,et al.Pregnancy-associated plasma protein A and proform eosinophilic major basic protein in the detection of different types of corollary artery disease[J].Physiol Res,2008,57:23-32.
  • 2Tousoulis D,Kampoli A,Stefanati E,et al.New biomarkers in acute coronary syndrome[J].Curt Med Chem,2008,15:1288-1296.
  • 3Arcar I,Zito F,Castelnuovoc A,et al.C reactive protein and its determinants in healthy men and women from Uropean regions at different risk of coronary disease:the IMMIDIET Project[J].J Thromb Haemost,2008,6:436-443.
  • 4Tobias P,Frank,Kathryn M,et al.Inflammation,the metabolic syndrome.and risk of coronary heart disease in women and men[J].Atherosclerosis,2008,197:392-399.
  • 5Li X,Zhou S,Tang J,et al.Association between plasma pregnancy-associated plasma protein A and restenosis after percutaneous coronary angioplasty[J].Cire J,2008,72:729-733.
  • 6Conover C,Harrlngton S,Bale K.Differential regulation of pregnancy associated plasma protein-A in human coronary artery endothelial cells and smooth muscle cells[J].Growth Hormone & IGF Research,2008,18:213-220.
  • 7Niccoli G,Biasucci L,Biscione C,et al.Independent prognostic value of C-reactive protein and coronary artery disease extent in patients affected by unstable angina[J].Atherosclerosis,2008,196:779-785.
  • 8Qin Q,Wittfooth S,Peterrson K.Measurement and clinical significance of circulating PAPP-A in ACS patients[J].Clini Chim Acta.2007.380:59-67.

同被引文献10

  • 1Koenig W,Khuseyinova N.Biomarkers of atheroscleroticplaque instability and rupture[J].Arterioscler Thromb VascBiol,2007,27:15.
  • 2Tousoulis D,Kampoli A,Stefanadi E,et al.New biomarkersin acute coronary syndrome[J].Curr Med Chem,2008,15:1288.
  • 3Rondina M,Lappe J,Carlquist J,et al.Soluble CD40 ligandas a predictor of coronary artery disease and long-termclinical outcomes in stable patients undergoing coronaryangiography[J].Cardiology,2008,6:436.
  • 4Fouad HH,Al Dera H,Bakhoum SW,et al.Levels of sCD40ligand in chronic and acute coronary syndromes and itsrelation to angiographic extent of coronary arterial narrowing[J].Angiology,2010,21(6):567-573.
  • 5Munk PS,Breland UM,Aukrust P,et al.Inflammatory res-ponse to percutaneous coronary intervention in stable coron-ary artery disease[J].J Thromb Thromboly,2011,31(1):92-98.
  • 6Blagodatskikh KA,Evdokimova MA,Agapkina YV,et al.The polymorphisms G(-174)C in IL6 gene and G(-1082)A inIL10 gene are associated with poor outcomes in patients withacute coronary syndrome[J].Mol Biol,2010,44(5):741-747.
  • 7Wang Y,Li L,Tan H,et al.Transcoronary concentrationgradient of sCD40 and hsCRP in patients with coronary heartdisease[J].Clin Cardiol,2007,30:392.
  • 8Wenzel F,Baertl A,Zimmermann N,et al.Different beha-viour of soluble CD40L concentrations can be reflected byvariations of preanlytical conditions[J].Clin Hemo Micro-circ,2008,39:417.
  • 9Spagnoli L,Bonanno E,Sangiorgi G,et al.Role ofinflammation in atherosclerosis[J].J Nucl Med,2007,48:1800.
  • 10Niccoli G,Biasucci L,Biscione C,et al.CD40 ligand prom-otes Mac-1 expression,leukocyte recruitment,and neointi-ma formation after vascular injury[J].Am J Pathol,2008,172:1141.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部